Atlas Trials

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC

Clinical trial NCT03226236 · WITHDRAWN

Trial details

NCT number
NCT03226236
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal CellVaccinationSecondary
Start date
2016-03-01
Primary completion
2019-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.